Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T12:45:19.408Z.
Calculation as of: 2026-10-06T12:45:19.408Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8d554412806125b06490580232e6d80b3120c6a72214b764814008bb1d876b03
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Ainos, Inc.
Market Cap
$9.79M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Ainos, Inc. (AIMD) | $9.79M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | N/A |
| HeartSciences Inc. (HSCS)vs › | $9.42M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.27M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $9.09M | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.74M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.76M | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
